As of 2025-08-18, the Fair Value of Bristol-Myers Squibb Co (BMY) is 12.41 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 48.44 USD, the upside of Bristol-Myers Squibb Co is -74.39%.
With the market price of 48.44 USD and our fair value calculation, Bristol-Myers Squibb Co (BMY) is not a good investment. Investing in Bmy stocks now will result in a potential loss of 74.39%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -9,015.00 | 6,994.00 | 6,327.00 | 8,025.00 | -8,948.00 | 676.60 |
| YoY growth | -362.14% | 177.58% | -9.54% | 26.84% | -211.50% | -75.75% |
| Market Cap (mil) | 98,579.27 |
| P/E | 19.52x |
| Forward P/E | 19.52x |
| EPS | 2.48 |
| Avg earnings growth rate | -75.75% |
| TTM earnings | 5,050.00 |